Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread
Cancer Treatment Reviews · 2023
DOI: 10.1016/j.ctrv.2023.102618 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2023. Verfasst von Carmen Criscitiello und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncolog…. Hauptthemen laut MEDLINE: Breast Neoplasms, Brain Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 82 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hematology-Oncology (DIPO), University of Milan, Milan, Italy. E…
- Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hematology-Oncology (DIPO), University of Milan, Milan, Italy.
- Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS 'Fondazione Pascale', Napoli, Italy.
- Department of Medical Oncology, Ospedale San Raffaele, IRCCS, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
- Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
- Medical Oncology Unit, Ospedale di Summa A. Perrino, Brindisi, Italy.
Zitieren
APA
Criscitiello, C., Corti, C., De Laurentiis, M., Bianchini, G., Pistilli, B., Cinieri, S., Castellan, L., Arpino, G., Conte, P., Di Meco, F., Gennari, A., Guarneri, V., Visani, L., Livi, L., Marchetti, P., Puglisi, F., Viale, G., Del Mastro, L., De Placido, S., & Curigliano, G. (2023). Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2023.102618
Vancouver
Criscitiello C, Corti C, De Laurentiis M, Bianchini G, Pistilli B, Cinieri S, et al. Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread. Cancer Treatment Reviews. 2023. doi:10.1016/j.ctrv.2023.102618
BibTeX
@article{Criscitiello2023,
author = {Criscitiello, Carmen and Corti, Chiara and De Laurentiis, Michelino and Bianchini, Giampaolo and Pistilli, Barbara and Cinieri, Saverio and Castellan, Lucio and Arpino, Grazia and Conte, Pierfranco and Di Meco, Francesco and Gennari, Alessandra and Guarneri, Valentina and Visani, Luca and Livi, Lorenzo and Marchetti, Paolo and Puglisi, Fabio and Viale, Giuseppe and Del Mastro, Lucia and De Placido, Sabino and Curigliano, Giuseppe},
title = {Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spread},
journal = {Cancer Treatment Reviews},
year = {2023},
doi = {10.1016/j.ctrv.2023.102618}
}
EUVIMED